{"count": 1, "results": [{"_id": "32156705", "pmid": 32156705, "pmcid": "PMC7213329", "title": "Metformin limits osteoarthritis development and progression through activation of AMPK signalling", "journal": "Ann Rheum Dis", "authors": ["Li J", "Zhang B", "Liu WX", "Lu K", "Pan H", "Wang T", "Oh CD", "Yi D", "Huang J", "Zhao L", "Ning G", "Xing C", "Xiao G", "Liu-Bryan R", "Feng S", "Chen D"], "date": "2020-05-01T00:00:00Z", "doi": "10.1136/annrheumdis-2019-216713", "meta_date_publication": "2020 May", "meta_volume": "79", "meta_issue": "5", "meta_pages": "635-645", "score": 50252.89, "text_hl": "The present study suggests that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, administered shortly after @<m>DISEASE_Elbow_Injuries</m> @DISEASE_MESH:D000092464 @@@joint injury@@@, can limit @DISEASE_Osteoarthritis @DISEASE_MESH:D010003 @@@OA@@@ development and progression in injury-induced @DISEASE_Osteoarthritis @DISEASE_MESH:D010003 @@@OA@@@ animal models.", "citations": {"NLM": "Li J, Zhang B, Liu WX, Lu K, Pan H, Wang T, Oh CD, Yi D, Huang J, Zhao L, Ning G, Xing C, Xiao G, Liu-Bryan R, Feng S, Chen D. Metformin limits osteoarthritis development and progression through activation of AMPK signalling Ann Rheum Dis. 2020 May;79(5):635-645. PMID: 32156705", "BibTeX": "@article{32156705, title={Metformin limits osteoarthritis development and progression through activation of AMPK signalling}, author={Li J and Zhang B and Liu WX and Lu K and Pan H and Wang T and Oh CD and Yi D and Huang J and Zhao L and Ning G and Xing C and Xiao G and Liu-Bryan R and Feng S and Chen D}, journal={Ann Rheum Dis}, volume={79}, number={5}, pages={635-645}}"}}]}